Cargando…

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)

Detalles Bibliográficos
Autores principales:	Powles, Thomas, Nickles, Dorothee, Van Allen, Eliezer, Chappey, Colombe, Zou, Wei, Kowanetz, Marcin, Kadel, Edward, Denker, Mitchell, Boyd, Zachary, Vogelzang, Nicholas, Kim, Joseph, Bellmunt, Joaquim, Loriot, Yohann, Drake, Charles G, O'Hear, Carol, Fasso, Marcella, Hegde, Priti, Mariathasan, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645499/ http://dx.doi.org/10.1186/2051-1426-3-S2-P83

Ejemplares similares

Myeloid cell biology and inhibition of anti-tumor immune responses by MPDL3280A in urothelial bladder cancer
por: Xiao, Yuanyuan, et al.
Publicado: (2014)

P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
por: Kowanetz, M, et al.
Publicado: (2014)

Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A
por: Kowanetz, Marcin, et al.
Publicado: (2014)

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1
por: Kohrt, Holbrook, et al.
Publicado: (2013)

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
por: Cha, E
Publicado: (2014)

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
por: Molinero, Luciana, et al.
Publicado: (2019)

Beyond evolution : human nature and the limits of evolutionary explanation /
por: O’Hear, Anthony
Publicado: (1997)

Introduction to the philosophy of science
por: O’Hear, Anthony
Publicado: (1989)

Introduction to the philosophy of science
por: O'Hear, Anthony
Publicado: (1989)

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
por: Carbognin, Luisa, et al.
Publicado: (2015)

Draft genome sequencing of the sugarcane hybrid SP80-3280
por: Riaño-Pachón, Diego Mauricio, et al.
Publicado: (2017)

Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab
por: Vennapusa, Bharathi, et al.
Publicado: (2019)

3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis
por: Huaman, Moises, et al.
Publicado: (2019)

C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients
por: Patil, Namrata S., et al.
Publicado: (2021)

Arabidopsis Ubiquitin-Conjugating Enzymes UBC7, UBC13, and UBC14 Are Required in Plant Responses to Multiple Stress Conditions
por: Feng, Hui, et al.
Publicado: (2020)

Arabidopsis Ubiquitin-Conjugating Enzymes UBC4, UBC5, and UBC6 Have Major Functions in Sugar Metabolism and Leaf Senescence
por: Wang, Sheng, et al.
Publicado: (2022)

Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
por: Fernández-Sainz, Jesús, et al.
Publicado: (2023)

Modeling UBC intrinsic excitability
por: Subramaniyam, Sathyaa, et al.
Publicado: (2011)

Quantitative proteome dataset profiling of UBC4 and UBC5 deletion strains in Saccharomyces cerevisiae
por: Rossio, Valentina, et al.
Publicado: (2022)

A BAC library of the SP80-3280 sugarcane variety (saccharum sp.) and its inferred microsynteny with the sorghum genome
por: Figueira, Thais Rezende e Silva, et al.
Publicado: (2012)

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
por: Kowanetz, Marcin, et al.
Publicado: (2018)

Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
por: Fehlings, Michael, et al.
Publicado: (2019)

Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer
por: Coffey, David G., et al.
Publicado: (2022)

Molecular determinants of response to PD-L1 blockade across tumor types
por: Banchereau, Romain, et al.
Publicado: (2021)

Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
por: Pal, Sumanta K., et al.
Publicado: (2021)

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
por: Wallin, Jeffrey J., et al.
Publicado: (2016)

Is Transthyretin a Regulator of Ubc9 SUMOylation?
por: Wieczorek, Elżbieta, et al.
Publicado: (2016)

LBODP030 A Rare Case Of Partial Lipodystrophy From Mpdl (mandibular Hypoplasia, Deafness, Progeroid, Lipodystrophy Syndrome) Due To Pold1 Gene Mutation
por: Majumdar, Sujoyeeta, et al.
Publicado: (2022)

Complex Structure of OspI and Ubc13: The Molecular Basis of Ubc13 Deamidation and Convergence of Bacterial and Host E2 Recognition
por: Fu, Panhan, et al.
Publicado: (2013)

Segregating out UbcH10's role in tumorigenesis
por: Short, Ben
Publicado: (2010)

Ubc9 expression predicts chemoresistance in breast cancer
por: Chen, Shi-Feng, et al.
Publicado: (2011)

Observation of an E2 (Ubc9)-homodimer by crystallography
por: Alontaga, Aileen Y., et al.
Publicado: (2016)

Ubiquitin-Conjugating Enzymes Ubc1 and Ubc4 Mediate the Turnover of Hap4, a Master Regulator of Mitochondrial Biogenesis in Saccharomyces cerevisiae
por: Capps, Denise, et al.
Publicado: (2022)

Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
por: Wang, Na-Na, et al.
Publicado: (2015)

Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma
por: Hoffman-Censits, Jean, et al.
Publicado: (2020)

Phosphorylation of Ubc9 by Cdk1 Enhances SUMOylation Activity
por: Su, Yee-Fun, et al.
Publicado: (2012)

microRNA-214-mediated UBC9 expression in glioma
por: Zhao, Zhiqiang, et al.
Publicado: (2012)

Review of the UBC Porcine Model of Traumatic Spinal Cord Injury
por: Kim, Kyoung-Tae, et al.
Publicado: (2018)

Ubc13: the Lys63 ubiquitin chain building machine
por: Hodge, Curtis D., et al.
Publicado: (2016)

UBC9 coordinates inflammation affecting development of bladder cancer
por: Huang, Xiaoliang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2t9t0tk061onka9vokjendppm9